ArticleInternational journal for equity in health2026
Nipah virus destroyed my personal, family, and social life: stories of the hardship faced by Nipah survivors in Bangladesh.
Article in International journal for equity in health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNipah virus (NiV) causes recurrent outbreaks in Bangladesh with high mortality and persistent health consequences among survivors. As outbreak detection and clinical management improve, the number of survivors is likely to increase, creating an urgent need for long-term clinical, psychosocial, and rehabilitation support.
objectiveTo explore the lived experience of NiV survivors in Bangladesh and how physical, psychological, social, and economic challenges shape life after acute illness.
methodsWe conducted a qualitative study with a phenomenological orientation among 27 adult NiV survivors in Bangladesh. Survivors were purposively selected to capture variation in sex, age, exposure route, years since illness, and severity of acute disease. Where survivors had substantial communication difficulties or limited recall of the acute illness, caregivers provided supplementary contextual information on illness and recovery. In-person, semi-structured interviews were conducted in May 2022. Data were analysed inductively using reflexive thematic analysis with analyst triangulation to enhance credibility.
resultsParticipants were interviewed between 2 and 21 years after illness. Survivors described persistent functional limitations, including fatigue, mobility and balance problems, headaches, and visual changes, as well as cognitive and emotional difficulties, including memory problems, irritability, sleep disturbance, and anxiety. These challenges altered daily routines, self-perception, and expectations for the future. Survivors also described stigma and fear of contagion in healthcare and community settings, which restricted social participation, education, and marriage prospects. Households experienced substantial economic hardship through income loss, borrowing, mortgaging land, and sale of assets to pay for treatment and recovery. Coping responses included practical adjustments and reliance on family support and religious faith, although many participants reported ongoing uncertainty about health, livelihoods, and the future.
conclusionsSurvivorship after Nipah virus infection in Bangladesh involves continuing functional, cognitive, psychosocial, and economic hardship that extends well beyond acute recovery. Priority actions include survivor-centred rehabilitation, brief mental health support, and counselling for caregivers on safe care practices. Stigma-sensitive risk communication and targeted financial support should also be integrated into existing Nipah surveillance and response systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.